Skip to main content
OpenTrials
Completed

NCT Number: NCT02627222

The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children

The study comprises an open-label randomized controlled trial investigating the efficacy of consuming a daily ration of pro-vitamin A biofortified cassava on vitamin A status of Nigerian children, aged 3-4 years old (n=200).

Completed

Looking for future studies?

Notify Me

Key information

Age range

36 month–59 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Human Nutrition, University of Ibadan

Ibadan, Nigeria

About this study

Objective: The primary objective is to assess the efficacy of daily consumption of pro-vitamin A rich cassava during 10 weeks on body retinol pools of 3-4 year old children in Nigeria after high-dose vitamin A supplementation. The secondary objectives are: 1) To investigate the effect of daily consumption of pro-vitamin A rich cassava on functional indicators such as nutritional anaemia and gut integrity; 2) To investigate the effect of zinc deficiency and genetic polymorphisms in the Beta-Carotene Oxygenase 1 (BCO1) and related genes on the efficacy of pro-vitamin A rich cassava consumption; 3) To compare the skin colour in the palm of the hand of each participant with their serum retinol levels using a handheld non-invasive spectrophotometer.

Study design: Open-label (single-blinded) randomized controlled trial with two parallel groups Study population: Pre-school children, aged 3-4 years living in Osun State area, South-Western Nigeria. Children (n=750) will be screened for eligibility. Out of these, n=250 will undergo a 4-week run-in phase. n=200 children will be randomly allocated to two different treatments: 1) Yellow cassava providing ~50% of the recommended daily allowance (RDA) for vitamin A; 2) White cassava.

Main study parameters/endpoints: The primary outcome was the difference in body retinol pools between groups 1 and 2 at the end of intervention; however, due to the inability to assess body retinol pools, the modified primary outcome is the difference in serum retinol concentrations between groups 1 and 2. Other outcome measures include: other vitamin A status indicators (β-carotene, retinol binding protein, transthyretin), inflammatory markers, iron status indicators, anthropometrics, gut integrity, and thyroid function.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 36 - 59 months (verified by birth certificates, vaccination cards or other formal documentation)
  • Apparently healthy
  • Parental informed consent

Exclusion criteria

  • Frequently absent (>20% of feeding days) during run-in
  • Children not assenting during blood collections
  • Signs or history of infectious or systemic diseases (e.g. tuberculosis, sickle cell anaemia)
  • Mental status that is incompatible with the proper conduct of the study
  • Current participation in other research
  • Food allergy related to the intervention foods

Treatment and study plan

Pro-vitamin A biofortified cassava

Other

Pro-vitamin A biofortified cassava is the product of international conventional breeding programs (non-GMO) in order to increase the pro-vitamin A content of cassava for improved nutritional intake

Other names: Yellow cassava, Biofortified cassava

White cassava

Other

Conventional white cassava

Other names: Cassava, Manihot esculenta

Primary outcomes

  1. Body retinol pool (omitted)

    Time frame: 13 weeks

    Difference in body retinol pools between groups

  2. (Modified primary outcome): Serum retinol

    Time frame: 13 weeks

    Difference in serum retinol pools between groups

Secondary outcomes

  1. Anaemia

    Time frame: 13 weeks

    Difference in haemoglobin concentration between groups

  2. Gut integrity

    Time frame: 11 weeks

    Difference in gut integrity between groups

Other outcomes

  1. Serum betacarotene

    Time frame: 13 weeks

    Difference in serum retinol concentration between groups

  2. Retinol binding protein

    Time frame: 13 weeks

    Difference in serum retinol binding protein concentration between groups

  3. Urinary thiocyanate

    Time frame: 11 weeks

    Difference in urinary thiocyanate concentration between groups

  4. Thyroid function indicators

    Time frame: 13 weeks

    Difference in serum thyroid function indicators between groups

  5. Serum zinc

    Time frame: Baseline

    Effect modification by baseline zinc deficiency

  6. Genetic polymorphisms in the BCO1 gene

    Time frame: Baseline

    Effect modification by BCO1 polymorphisms

  7. Inflammatory markers

    Time frame: Baseline and end of study

    C-reactive protein, alpha glycoprotein

  8. Malaria

    Time frame: Baseline and end of study

    A-symptomatic malaria

Sponsors and collaborators

Lead sponsor

Wageningen University

Other

Collaborators

  • International Institute for Tropical Agriculture
  • University of Ibadan

Registry information

Acronym: CASSAVITA II

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Dec 10, 2015
Registry last updated
Feb 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.